Unicycive Therapeutics (NASDAQ:UNCY - Get Free Report) is expected to post its quarterly earnings results before the market opens on Thursday, March 27th. Analysts expect Unicycive Therapeutics to post earnings of ($0.13) per share for the quarter.
Unicycive Therapeutics Trading Up 4.8 %
Unicycive Therapeutics stock traded up $0.03 during mid-day trading on Friday, reaching $0.68. The company's stock had a trading volume of 1,877,254 shares, compared to its average volume of 1,394,939. The firm has a market cap of $70.58 million, a price-to-earnings ratio of -0.70 and a beta of 2.26. The business has a 50 day moving average price of $0.59 and a 200-day moving average price of $0.56. Unicycive Therapeutics has a twelve month low of $0.20 and a twelve month high of $1.60.
Analyst Upgrades and Downgrades
Separately, HC Wainwright restated a "buy" rating and issued a $4.00 price target on shares of Unicycive Therapeutics in a research report on Wednesday, January 29th.
Check Out Our Latest Report on Unicycive Therapeutics
About Unicycive Therapeutics
(
Get Free Report)
Unicycive Therapeutics, Inc, a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI 494, which is in Phase 1 clinical trials for treatment of acute kidney injury.
Recommended Stories
Before you consider Unicycive Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicycive Therapeutics wasn't on the list.
While Unicycive Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
